Ignite Creation Date:
2025-12-25 @ 4:42 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT04379518
Status:
SUSPENDED
Last Update Posted:
2023-03-06
First Post:
2020-05-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-17
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-11-17
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-06
First Submit QC Date:
None
Study First Post Date:
2020-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-02
Last Update Post Date:
2023-03-06
Last Update Post Date Type:
ACTUAL